HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of IL-22 and IL-22RA1 gene variants in Iranian patients with colorectal cancer.

AbstractAIM:
In the current study, it was hypothesized that single nucleotide polymorphisms (SNPs) in the regulatory region of the IL-22 signaling pathway genes, including IL-22 and IL-22RA1 variants, may be associated with CRC susceptibility.
BACKGROUND:
The important role of pro-inflammatory cytokines during tumorigenesis is well-established. In recent years, IL-22 has been linked with colorectal cancer (CRC) through a number of mechanistic and observational studies.
METHODS:
The association of four polymorphisms in the IL-22 (rs1179251 and rs1179246) and IL-22RA1 (rs4648936 and rs10794665) genes with CRC risk were studied using a case-control design with 304 cases and 345 controls from the Iranian population. All 649 subjects were evaluated by PCR-RFLP method.
RESULTS:
No significant difference was found in genotype and allele frequencies between the cases and controls for either IL-22 and IL-22RA1 gene variants or CRC risk before or after adjusting for confounders.
CONCLUSION:
The current findings do not present any significant evidence for associations between variants in IL-22 signaling pathway genes and CRC. Complementary studies with greater sample sizes may be necessary to fully elucidate the nature of these associations.
AuthorsSeyed Reza Mohebbi, Khatoon Karimi, Fatemeh Rostami, Shabnam Kazemian, Pedram Azimzadeh, Hanieh Mirtalebi, Ehsan Nazemalhosseini-Mojarad, Hamid Asadzadeh Aghdaei, Reza Vafaee, Mohammad Hossain Heydari
JournalGastroenterology and hepatology from bed to bench (Gastroenterol Hepatol Bed Bench) Vol. 14 Issue Suppl1 Pg. S58-S65 ( 2021) ISSN: 2008-2258 [Print] Iran
PMID35154603 (Publication Type: Journal Article)
Copyright©2021 RIGLD, Research Institute for Gastroenterology and Liver Diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: